Canagliflozin/Metformin Combo Approved as First Line for DiabetesCanagliflozin/Metformin Combo Approved as First Line for Diabetes
The fixed-dose combination product of canagliflozin and metformin, known as Invokamet, has been approved for first-line treatment of type 2 diabetes in the US. News Alerts
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
More News: Canagliflozin | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Invokana | Metformin